Cargando…
STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
Constitutively activated STAT3 plays an essential role in the initiation, progression, maintenance, malignancy, and drug resistance of cancer, including glioblastoma, suggesting that STAT3 is a potential therapeutic target for cancer therapy. We recently identified ODZ10117 as a small molecule inhib...
Autores principales: | Kim, Byung-Hak, Lee, Haeri, Park, Cheol Gyu, Jeong, Ae Jin, Lee, Song-Hee, Noh, Kum Hee, Park, Jong Bae, Lee, Chung-Gi, Paek, Sun Ha, Kim, Hyunggee, Ye, Sang-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140655/ https://www.ncbi.nlm.nih.gov/pubmed/32183406 http://dx.doi.org/10.3390/cells9030722 |
Ejemplares similares
-
Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
por: Kim, Byung-Hak, et al.
Publicado: (2019) -
Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
por: Kang, Ju-Hui, et al.
Publicado: (2023) -
Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
por: Noh, Kum Hee, et al.
Publicado: (2021) -
Glioblastoma invasion factor ODZ1 is induced by microenvironmental signals through activation of a Stat3-dependent transcriptional pathway
por: Vidal, Veronica, et al.
Publicado: (2021) -
HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells
por: Carcelén, María, et al.
Publicado: (2022)